End-of-life care in adults with congenital heart disease: Now is the time to act

Current Opinion in Supportive and Palliative Care

Volumn 7, Issue 1, 2013, Pages 8-13

  Bowater, Sarah E ^a   Speakman, John K ^a   Thorne, Sara A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Congenital heart disease; Palliative care; Young patient

Indexed keywords

ADULT; COMORBIDITY; CONGENITAL HEART MALFORMATION; DISEASE COURSE; HUMAN; LIFE EXPECTANCY; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; PATIENT CARE; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW; STANDARD; TRANSITION TO ADULT CARE;

ADULT; ADVANCE CARE PLANNING; COMORBIDITY; DISEASE PROGRESSION; HEART DEFECTS, CONGENITAL; HUMANS; LIFE EXPECTANCY; MIDDLE AGED; PALLIATIVE CARE; PATIENT-CENTERED CARE; PREVALENCE; TRANSITION TO ADULT CARE;

EID: 84877946771     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e32835c0707     Document Type: Review

References (43)

1. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the general population. Circulation 2007;115:163-172.
2. Macmahon B, Mckeown T, Record RG. The incidence and life expectancy of children with congenital heart disease. Br Heart J 1953;15:121-129.
3. Moons P, Bovijn L, Budts W, et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium /clinical perspective. Circulation 2010;122:2264-2272.
4. Gilboa SM, Salemi JL, Nembhard WN, et al. Mortality resulting from congenital heart disease among children and adults in the United States 1999 to 2006/clinical perspective. Circulation 2010;122:2254-2263. This large population-based study examines the mortality trends in CHD across the USA . It demonstrates a declining mortality in both children and adults.
5. Warnes CA, Liberthson R, Danielson J, et al. Task Force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol 2001;37:1170-1175.
6. Silversides CK, Salehian O, Oechslin E, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions. Can J Cardiol 2010;26:e98-e117.
7. Khairy P, Ionescu-Ittu R, Mackie AS et al. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010;56:1149-1157.
8. Afilalo J, Therrien J, Pilote L, Ionescu-Ittu R, et al. Geriatric congenital heart disease: burden of disease and predictors of mortality. J Am Coll Cardiol 2011;58:1509-1515.
9. Tobler D, de Stoutz NM, Greutmann M. Supportive and palliative care for adults dying from congenital heart defect. Curr Opin Support Palliat Care 2011;5.
10. Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. Mortality in adult congenital heart disease. Eur Heart J 2010;31:1220-1229.
11. Hoffmann A, Wyler F, Gunthard J, Gradel E. Late follow-up of patients who underwent palliation for complex congenital heart disease in childhood. Congenit Heart Dis 2008;3:155-158.
12. Gersony WM. Fontan operation after 3 decades: what we have learned. Circulation 2008;117:13-15.
13. Ohuchi H, Kagisaki K, Miyazaki A, et al. Impact of the evolution of the Fontan operation on early and late mortality: a single-center experience of 405 patients over 3 decades. Ann Thorac Surg 2011;92:1457-1466. This is a large single-centre study from Japan examining how their changing surgical approach has improved the outcome in patients undergoing a Fontan operation.
14. Khairy P, Fernandes SM, Mayer JEJ, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 2008;117:85-92.
15. Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients. The first 15 years. J Am Coll Cardiol 2006;47:2065-2073.
16. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe : morbidity and mortality in a 5 year follow-up period. Eur Heart J 2005;26:2325-2333.
17. Stumper O. Hypoplastic left heart syndrome. Heart 2010;96:231-236.
18. Feinstein JA, Benson DW, Dubin AM, et al. Hypoplastic left heart syndrome. Current considerations and expectations. J Am Coll Cardiol 2012;59:S1-S42. An extensive and up-to-date review of hypoplastic left heart syndrome including the most recent outcome data and the potential long-term complications these patients will encounter.
19. Huddleston C. The failing Fontan: options for surgical therapy. Pediatr Cardiol 2007;28:472-476.
20. Giamberti A, Chessa M, Abella R, et al. Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 2009;88:1284-1289.
21. Deal BJ, Jacobs ML. Management of the failing Fontan circulation. Heart 2012;98:1098-1104. A thorough review of the medical and surgical management of the failing Fontan. They do not, however, mention the need for palliative care involvement in these patients.
22. Patel ND, Weiss ES, Allen JG, et al. Heart transplantation for adults with congenital heart disease: analysis of the United Network for Organ Sharing Database. Ann Thorac Surg 2009;88:814-822.
23. Davies RR, Russo MJ, Yang J, et al. Listing and transplanting adults with congenital heart disease/clinical perspective. Circulation 2011;123:759- 767. An excellent review of the outcome in all patients (41 000) listed for cardiac transplantation across the USA specifically looking at those with CHD.
24. Irving C, Parry G, O'Sullivan J, et al. Cardiac transplantation in adults with congenital heart disease. Heart 2010;96:1217-1222.
25. Kapadia JY, Pierce KC, Poupore AK Throckmorton AL. Hydraulic testing of intravascular axial flow blood pump designs with a protective cage of filaments for mechanical cavopulmonary assist. ASAIO J 2010;56. 26.
26. Swetz KM, Freeman MR, AbouEzzeddine OF, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc 2011;86:493-500.
27. Larner AJ. Searching the Internet for medical information: frequency over time and by age and gender in an outpatient population in the UK . J Telemed Telecare 2006;12:186-188.
28. Gordon M', Capell HA, Madhok R. The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology 2002;41:1402-1405.
29. Catherine M, Paul S, Lorraine W, et al. Information needs of cancer patients in west Scotland : cross sectional survey of patients' views. BMJ 1996;313.
30. McCarthy M, Hall JA, Ley M. Communication and choice in dying from heart disease. J R Soc Med 1997;90:128-131.
31. Gibbs JSR, McCoy ASM, Gibbs LME, et al. Living with and dying from heart failure: the role of palliative care. Heart 2002;88:ii36-ii39.
32. Wright AAZB. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 2008;300:1665-1673.
33. Tobler D, Greutmann M, Colman JM, et al. End-of-life in adults with congenital heart disease: a call for early communication. Int J Cardiol 2012;155:383-387. The first of the two studies by the Toronto-based group looking specifically at communication in ACHD. This study focusses on the communication of end-of-life issues in a clinic setting.
34. Tobler D, Greutmann M, Colman JM, et al. End-of-life care in hospitalized adults with complex congenital heart disease: care delayed, care denied. Palliat Med 2012;26:72-79. The second study from this group highlights the lack of discussion about EOL in ACHD patients who die in hospital.
35. Mathieu P. What's your expiry date? Ontario : Patrick Mathieu Unlimited;2005.
36. Badger JM. Factors that enable or complicate end-of-life transitions in critical care. Am J Crit Care 2005;14:513-521.
37. Bell C, Skiles J, Pradhan K, Champion V. End-of-life experiences in adolescents dying with cancer. Support Care Cancer 2010;18:827-835.
38. Brown VA, Parker PA, Furber RL, Thomas AL. Patient preferences for the delivery of bad news: the experience of a UK Cancer Centre. Eur J Cancer Care 2011;20:56-61.
39. Wein S, Pery S, Zer A. Role of palliative care in adolescent and young adult oncology. J Clin Oncol 2010;28:4819-4824. This review of the specific palliative care needs of young people is largely based on the author's extensive experience and is illustrated with case histories.
40. Pousset G. Medical end-of-life decisions in children in Flanders , Belgium : a population-based postmortem survey. Arch Pediatr Adolesc Med 2010;164:547-553.
41. Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol 2010. 28.4810-4818.
42. Bourke SJ, Doe SJ, Gascoigne AD, et al. An integrated model of provision of palliative care to patients with cystic fibrosis. Palliat Med 2009;23:512-517.
43. Braithwaite M, Philip J, Tranberg H, et al. End of life care in CF: patients, families and staff experiences and unmet needs. J Cyst Fibros 2011;10:253-257. This study examines the role of palliative care in a nonmalignant disease and uses focus group interviews. Whilst this looks at cystic fibrosis patients, there are many parallels that can be drawn for CHD.